Content Spotlight
Podcast: Sustainability equals efficiency, says eXmoor
eXmoor Pharma discusses the steps taken to build a more sustainable facility, the importance of its design, and calls for industry to share advice and initiatives.
Latest News
The Framingham biomanufactuiring facility near Boston has received a US FDA warning letter
Facilities & CapacityFDA cites contamination concerns in warning to Sanofi MA plant
FDA cites contamination concerns in warning to Sanofi MA plant
Approximately 20% of bioreactor runs over 30 months were rejected due to contamination issues at Sanofi’s Framingham biologics facility, according to the US FDA.
Deal-Making
Axovia teams with Viralgen to manufacture BBS gene therapyAxovia teams with Viralgen to manufacture BBS gene therapy
The companies will rely on AskBio’s Pro10 manufacturing platform to target retinal degeneration.
Deal-Making
Iconovo taps Lonza for spray-dried obesity biologicIconovo taps Lonza for spray-dried obesity biologic
Lonza joins the race for weight loss drugs with plans to produce an active pharmaceutical ingredient (API) for Iconovo’s intranasal biologic.
Facilities & Capacity
Sartorius, McMaster open Canadian bioprocessing hubSartorius, McMaster open Canadian bioprocessing hub
Sartorius and McMaster University have opened a 1,600 square-foot bioprocess research facility in Hamilton, Ontario, about 38 miles south of Toronto.
Upstream & Downstream Processing
Incyte and Syndax to scale Niktimvo production after FDA approvalIncyte and Syndax to scale Niktimvo production after FDA approval
With the graft-versus-host disease (GVHD) drug available in the US, the company and its partner Syndax prepare for a robust commercial launch.
Global Markets
Samsung Bio lands $1.4bn contract with undisclosed EU clientSamsung Bio lands $1.4bn contract with undisclosed EU client
Contract development and manufacturing organization (CDMO) Samsung Biologics will provide manufacturing services for the client in what it calls its ‘largest ever contract’.
Facilities & Capacity
Aragen $100m PE boost to bolster CDMO ambition in India and beyondAragen $100m PE boost to bolster CDMO ambition in India and beyond
Indian CDMO Aragen has laid out aggressive expansion plans for capacity and multi-modality services following a $100 million investment from Singapore-based private equity (PE) fund Quadria Capital.
Regulations
FDA cites contamination concerns in warning to Sanofi MA plantFDA cites contamination concerns in warning to Sanofi MA plant
Approximately 20% of bioreactor runs over 30 months were rejected due to contamination issues at Sanofi’s Framingham biologics facility, according to the US FDA.
Regulations
Department of Commerce cracks down on biotechnology exportsDepartment of Commerce cracks down on biotechnology exports
With BIOSECURE in limbo, the US government seeks other ways to protect American interests.
Therapeutic Class
Axovia teams with Viralgen to manufacture BBS gene therapyAxovia teams with Viralgen to manufacture BBS gene therapy
The companies will rely on AskBio’s Pro10 manufacturing platform to target retinal degeneration.
Therapeutic Class
BioProcess Insider is back with a Gen Z twist, breaking down 2025’s hottest bioprocessing trends – because the future of CGTs and GLP-1s is straight fire.
Upstream & Downstream Processing
Sartorius, McMaster open Canadian bioprocessing hubSartorius, McMaster open Canadian bioprocessing hub
Sartorius and McMaster University have opened a 1,600 square-foot bioprocess research facility in Hamilton, Ontario, about 38 miles south of Toronto.
Upstream & Downstream Processing
Incyte and Syndax to scale Niktimvo production after FDA approvalIncyte and Syndax to scale Niktimvo production after FDA approval
With the graft-versus-host disease (GVHD) drug available in the US, the company and its partner Syndax prepare for a robust commercial launch.